Baker Bros. Advisors’s Ambit Biosciences Corp AMBI Stock Holding History

Baker Bros. Advisors’s Portfolio AMBI Stock Details AMBI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q4	–	Sell	-1,093,332	Closed	-$16.8M	–	123
2014 Q3	$16.8M	Buy	1,093,332 +345,378	+46%	+$2.37M	0.21%	39
2014 Q2	$5.17M	Hold	747,954	–	–	0.06%	68
2014 Q1	$6.82M	Hold	747,954	–	–	0.09%	60
2013 Q4	$7.21M	Sell	747,954 -8	-0%	-$107	0.1%	54
2013 Q3	$11.6M	Hold	747,962	–	–	0.16%	40
2013 Q2	$5.24M	Buy	+747,962	New	+$5.35M	0.1%	46

Baker Bros. Advisors's AMBI Position: Q4 2014 in Review

Baker Bros. Advisors sold out of Ambit Biosciences Corp (AMBI) in Q4 2014, closing a stake of 1,093,332 shares — an estimated $16.8M sold.

Baker Bros. Advisors first reported a position in AMBI in Q2 2013 and held it in 6 quarters. The position peaked at $16.8M in Q3 2014. 0 funds tracked by Wall St. Rank hold AMBI as of Q4 2014.

Baker Bros. Advisors reported no remaining Ambit Biosciences Corp position as of Q4 2014 after selling out during the quarter.
Baker Bros. Advisors sold 1,093,332 Ambit Biosciences Corp shares in Q4 2014, an estimated $16.8M.
Baker Bros. Advisors first reported a position in Ambit Biosciences Corp in Q2 2013 and held it in 6 quarters.
Baker Bros. Advisors's Ambit Biosciences Corp position peaked at $16.8M in Q3 2014.
0 funds tracked by Wall St. Rank held Ambit Biosciences Corp as of Q4 2014.

Based on Baker Bros. Advisors's 13F filing for Q4 2014, filed 17 Feb 2015.